These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort. Cronin CA; Langenberg P; Dutta TM; Kittner SJ Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551 [TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451 [TBL] [Abstract][Full Text] [Related]
12. Role of tissue plasminogen activator in acute ischemic stroke. Hatcher MA; Starr JA Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027 [TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic therapy for acute stroke: the Spanish experience. ECASS-II Spanish Group. Dávalos A Cerebrovasc Dis; 1999; 9 Suppl 3():9-15. PubMed ID: 10436320 [No Abstract] [Full Text] [Related]
14. TPA for acute ischemic stroke. Fischer J S D J Med; 1997 Feb; 50(2):69-70. PubMed ID: 9062450 [No Abstract] [Full Text] [Related]
15. Stroke busters. New treatments in the fight against 'brain attacks'. Schrof JM US News World Rep; 1999 Mar; 126(10):62-4, 68. PubMed ID: 10346396 [No Abstract] [Full Text] [Related]